Case Study

World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed

IQVIA and Advarra partnered to advance Operation Warp Speed COVID-19 vaccine trials and deliver exemplary service to sponsors and clinical research sites.

The results:

  • IBC approval timelines reduced to under 2 working days
  • Participating sites approved 78% faster
  • Sites activated to “ready to enroll” 71% faster
  • Trial results delivered to sponsor quicker than expected

To learn more, download the case study.

Who should watch?

text goes here

CEU Credits

text goes here

Certificate of Attendance

text goes here

Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour

Access Now